The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Dorsch Marion since 2017.
This trader's CIK number is 1690460.
At the time of last reporting, Dorsch Marion was the Chief Scientific Officer of Blueprint Medicines Corp. (stock ticker symbol BPMC).
Also see all insider trading activities at Blueprint Medicines Corp.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | BPMC | 0 | $0 | 7,578 | $757,800 | 7,578 | $281,219 |
| 2020 | BPMC | 0 | $0 | 20,150 | $1,868,248 | 18,400 | $682,824 |
| 2019 | BPMC | 0 | $0 | 11,500 | $1,013,752 | 11,500 | $426,765 |
| 2018 | BPMC | 0 | $0 | 4,600 | $393,949 | 4,600 | $170,706 |
| 2017 | BPMC | 0 | $0 | 27,500 | $1,843,505 | 27,500 | $1,020,524 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-02-22 | BPMC | Option Ex | 7,578 | 37.11 | 281,219 |
| 2021-02-22 | BPMC | Sale | 7,578 | 100.00 | 757,800 |
| 2020-12-14 | BPMC | Option Ex | 4,600 | 37.11 | 170,706 |
| 2020-12-14 | BPMC | Sale | 4,600 | 119.00 | 547,400 |
| 2020-10-06 | BPMC | Option Ex | 4,600 | 37.11 | 170,706 |
| 2020-10-06 | BPMC | Sale | 4,600 | 99.00 | 455,400 |
| 2020-09-23 | BPMC | Sale | 4,600 | 89.00 | 409,400 |
| 2020-09-23 | BPMC | Option Ex | 4,600 | 37.11 | 170,706 |
| 2020-06-19 | BPMC | Option Ex | 4,600 | 37.11 | 170,706 |
| 2020-06-19 | BPMC | Sale | 4,600 | 79.00 | 363,400 |
| 2020-03-23 | BPMC | Sale | 1,214 | 53.36 | 64,782 |
| 2020-03-09 | BPMC | Sale | 536 | 51.99 | 27,866 |
| 2019-12-19 | BPMC | Option Ex | 4,600 | 37.11 | 170,706 |
| 2019-12-19 | BPMC | Sale | 4,600 | 79.00 | 363,400 |
| 2019-06-17 | BPMC | Option Ex | 4,600 | 37.11 | 170,706 |
| 2019-06-17 | BPMC | Sale | 4,600 | 99.00 | 455,400 |
| 2019-03-04 | BPMC | Option Ex | 2,300 | 37.11 | 85,353 |
| 2019-03-04 | BPMC | Sale | 2,300 | 84.76 | 194,952 |
| 2018-09-17 | BPMC | Sale | 2,300 | 71.21 | 163,789 |
| 2018-09-17 | BPMC | Option Ex | 2,300 | 37.11 | 85,353 |
| 2018-03-15 | BPMC | Option Ex | 2,300 | 37.11 | 85,353 |
| 2018-03-15 | BPMC | Sale | 2,300 | 100.07 | 230,160 |
| 2017-11-22 | BPMC | Option Ex | 9,166 | 37.11 | 340,150 |
| 2017-11-22 | BPMC | Sale | 9,166 | 70.00 | 641,620 |
| 2017-11-21 | BPMC | Option Ex | 18,334 | 37.11 | 680,374 |
| 2017-11-21 | BPMC | Sale | 18,334 | 65.56 | 1,201,885 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Dorsch Marion (Chief Scientific Officer of Blueprint Medicines Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.